Friday, May 1, 2020

Dr. Bonnie Henry says she's excited about news of success with experimental drug for COVID-19

CBC is reporting that "B.C.'s provincial health officer says she's cautiously optimistic about a new study on the experimental antiviral drug remdesivir's effects on COVID-19. American officials revealed this week that research conducted by the U.S. National Institutes of Health found remdesivir reduced recovery time by 31 per cent in COVID-19 patients - from 15 to 11 days on average. During her daily briefing on Thursday, Dr. Bonnie Henry described those results as good news." I told ya so. There is a Vaccine. There always was one.

"Remdesivir is an antiviral drug, which means it doesn't prevent infection, but it makes it more difficult for the virus to reproduce and spread through the body. It's manufactured by Gilead Sciences Inc., and the U.S. Food and Drug Administration is now reportedly working to make the drug quickly available to patients."

"Dr. Anthony Fauci has said he expects the Food and Drug Administration to fast-track approval of the drug, which was shown in a study to shorten recovery time of hospitalized patients."

All you need to know about Gilead's experimental antiviral drug Remdesivir

Addressing Vaccine Hesitancy with Exemptions. It's experimental. You can't make it mandatory.

The Food and Drug Administration cleared remdesivir for hospitalized severe patients

No comments:

Post a Comment

Comments are moderated so there will be a delay before they appear on the blog.